{"id":"W2946162392","doi":"10.3390/ph12020078","title":"Tegsedi (Inotersen): An Antisense Oligonucleotide Approved for the Treatment of Adult Patients with Hereditary Transthyretin Amyloidosis","year":2019,"lang":"en","type":"article","venue":"Pharmaceuticals","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":73,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Fundação para a Ciência e a Tecnologia; Horizon 2020 Framework Programme","keywords":"Transthyretin; Amyloidosis; Medicine; Polyneuropathy; Amyloid polyneuropathy; European commission; Cardiac amyloidosis; Oligonucleotide; Amyloid (mycology); Pharmacology; Internal medicine; Pathology; Disease; DNA; Genetics; Biology; European union; Business","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002672995,0.000167889,0.0002767744,0.000211341,0.0001322818,0.0002392749,0.0001211787,0.0003156439,0.002791819],"category_scores_gemma":[0.0003359922,0.00003355776,0.000273502,0.0002041642,0.0001251676,0.0001856255,0.0001720158,0.0006716989,0.0007106196],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002273646,"about_ca_system_score_gemma":0.0002274616,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004129221,"about_ca_topic_score_gemma":0.001030079,"domain_scores_codex":[0.9999064,0.00002019274,0.00001137329,0.00001518288,0.00003306488,0.00001382875],"domain_scores_gemma":[0.9998658,0.00003043444,0.00004135076,0.000004518127,0.00002701086,0.00003079384],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.007891453,0.001097164,0.01005238,0.001440855,0.0002720165,0.001289698,0.0002162748,0.0003292914,0.07517513,0.001552707,0.02212757,0.8785554],"study_design_scores_gemma":[0.01599864,0.04762229,0.09488666,0.001363583,0.001582926,0.02821475,0.0003314122,0.001958627,0.1204394,0.002063855,0.6854358,0.0001021497],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"review","genre_scores_codex":[0.7239667,0.1988212,0.005487143,0.004139074,0.001097508,0.0008931301,0.003218815,0.0006738865,0.06170261],"genre_scores_gemma":[0.9218571,0.04749165,0.006281011,0.003021358,0.0002832871,0.0003553887,0.003517684,0.00004660333,0.01714585],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.002791819,"threshold_uncertainty_score":0.009339571,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01557907895554995,"score_gpt":0.2934575134184402,"score_spread":0.2778784344628902,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}